Literature DB >> 17109342

Human papillomavirus prevalence in women who have and have not undergone hysterectomies.

Philip E Castle1, Mark Schiffman, Andrew G Glass, Brenda B Rush, David R Scott, Sholom Wacholder, Anne Dunn, Robert D Burk.   

Abstract

We compared human papillomavirus (HPV) prevalence in an age-stratified random sample of women who have undergone a hysterectomy (WH) (n=573) with the HPV prevalence in age-matched women with intact cervices (women who have not undergone a hysterectomy [WNH]) (n=581) participating in a study at Kaiser Permanente in Portland, Oregon. Testing cervicovaginal lavage fluids for >40 HPV genotypes using an MY09/11 L1 consensus primer polymerase chain reaction method, we found no statistical differences in the prevalence of HPV (16% for WNH vs. 13.9% for WH) or carcinogenic HPV (6.5% for WNH vs. 4.5% for WH) between the 2 groups of women. Although WH have a similar prevalence of carcinogenic HPV infection, compared with WNH without a cervix, they have minimal risk of HPV-induced cancer and are unlikely to benefit from HPV testing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109342     DOI: 10.1086/509511

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon.

Authors:  Adebola Adedimeji; Rogers Ajeh; Anastase Dzudie; Ernestine Kendowo; Norbert Fuhngwa; Denis Nsame; Andre Gaetan Simo-Wambo; Enow Orock; Tiffany M Hebert; Amanda J Pierz; Daniel Murokora; Kathryn Anastos; Philip E Castle
Journal:  J Clin Virol       Date:  2020-05-19       Impact factor: 3.168

Review 2.  A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results.

Authors:  Michelle J Khan; L Stewart Massad; Walter Kinney; Michael A Gold; E J Mayeaux; Teresa M Darragh; Philip E Castle; David Chelmow; Herschel W Lawson; Warner K Huh
Journal:  Gynecol Oncol       Date:  2016-02-22       Impact factor: 5.482

3.  Cervicovaginal human papillomavirus (HPV)-infection before and after hysterectomy: evidence of different tissue tropism for oncogenic and nononcogenic HPV types in a cohort of HIV-positive and HIV-negative women.

Authors:  Gypsyamber D'Souza; Robert D Burk; Ye Zhong; Howard Minkoff; L Stewart Massad; Xiaonan Xue; D Heather Watts; Kathryn Anastos; Joel M Palefsky; Alexandra M Levine; Christine Colie; Philip E Castle; Howard D Strickler
Journal:  Int J Cancer       Date:  2012-01-03       Impact factor: 7.396

4.  Prevalence of high-risk human papillomavirus among older women.

Authors:  Stacy Tessler Lindau; Melinda L Drum; Elyzabeth Gaumer; Hanna Surawska; Jeanne A Jordan
Journal:  Obstet Gynecol       Date:  2008-11       Impact factor: 7.661

5.  A comparison of cervical and vaginal human papillomavirus.

Authors:  Philip E Castle; Ana C Rodriguez; Carolina Porras; Rolando Herrero; Mark Schiffman; Paula Gonzalez; Allan Hildesheim; Robert D Burk
Journal:  Sex Transm Dis       Date:  2007-11       Impact factor: 2.830

6.  Vaginal cells of smokers are more resistant to human papillomavirus infection than that of non-smokers.

Authors:  Afsoon Moktar; Srivani Ravoori; Manicka V Vadhanam; Jianmin Pan; Shesh N Rai; Alfred B Jenson; Lynn P Parker; Ramesh C Gupta
Journal:  Exp Mol Pathol       Date:  2012-11-05       Impact factor: 3.362

7.  Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.

Authors:  Fang-Hui Zhao; Adam K Lewkowitz; Feng Chen; Margaret J Lin; Shang-Ying Hu; Xun Zhang; Qin-Jing Pan; Jun-Fei Ma; Mayineur Niyazi; Chang-Qing Li; Shu-Min Li; Jennifer S Smith; Jerome L Belinson; You-Lin Qiao; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2012-01-23       Impact factor: 13.506

8.  Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.

Authors:  Sari L Reisner; Madeline B Deutsch; Sarah M Peitzmeier; Jaclyn M White Hughto; Timothy P Cavanaugh; Dana J Pardee; Sarah A McLean; Lori A Panther; Marcy Gelman; Matthew J Mimiaga; Jennifer E Potter
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

9.  Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta.

Authors:  Philip E Castle; Julia C Gage; Edward E Partridge; Alfio Rausa; Patti E Gravitt; Isabel C Scarinci
Journal:  BMC Infect Dis       Date:  2013-01-07       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.